Mark A van Buchem Selected Research

Mark A van Buchem Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2008
14	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 10/2011
11	Cognitive Dysfunction 01/2022 - 04/2012
11	Dementia (Dementias) 01/2021 - 04/2007
9	Familial Cerebral Amyloid Angiopathy 01/2018 - 09/2009
7	Hypertension (High Blood Pressure) 01/2022 - 01/2009
5	Migraine Disorders (Migraine) 01/2022 - 01/2004
5	Atrophy 12/2017 - 07/2012
5	Type 2 Diabetes Mellitus (MODY) 05/2015 - 09/2009
4	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 02/2013
4	Amyloid Plaque 10/2019 - 06/2011
4	Central Nervous System Lupus Vasculitis 01/2018 - 01/2006
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 01/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2015 - 01/2013
3	App-Related Cerebroarterial Amyloidosis 01/2022 - 10/2019
3	Cerebral Small Vessel Diseases 01/2022 - 12/2012
3	Disease Progression 01/2018 - 01/2014
3	Vascular Diseases (Vascular Disease) 01/2018 - 08/2005
3	Epilepsy (Aura) 01/2018 - 01/2004
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017 - 09/2014
3	Hemorrhage 10/2016 - 06/2008
3	Inflammation (Inflammations) 01/2016 - 04/2002
2	Atrial Fibrillation 01/2022 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 11/2017
2	Infarction (Infarctions) 01/2022 - 01/2019
2	Cerebral Infarction 01/2019 - 01/2006
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 12/2012
2	Headache (Headaches) 01/2018 - 10/2006
2	Sciatica (Sciatic Neuralgia) 10/2017 - 05/2009
2	Intervertebral Disc Displacement (Herniated Disc) 10/2017 - 05/2009
2	Amyloidosis 02/2017 - 12/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 08/2015
2	Diabetes Mellitus 08/2015 - 01/2013
2	Insulin Resistance 08/2015 - 01/2015
2	CADASIL 12/2012 - 12/2010
2	Huntington Disease (Huntington's Disease) 07/2012 - 03/2011
2	Stroke (Strokes) 02/2011 - 01/2009
2	Rheumatoid Arthritis 11/2009 - 04/2004
2	Microaneurysm 05/2009 - 06/2008
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hemorrhagic Stroke 10/2019
1	Intracranial Embolism 01/2019
1	Geographic Atrophy 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Neurobehavioral Manifestations 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Albuminuria 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2017

Drug/Important Bio-Agent (IBA)

21	Amyloid (Amyloid Fibrils)IBA 01/2022 - 05/2011
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2008
11	IronIBA 01/2018 - 05/2011
7	Pravastatin (Pravachol)FDA LinkGeneric 01/2022 - 08/2005
6	Glucose (Dextrose)FDA LinkGeneric 08/2015 - 09/2009
4	Retinaldehyde (Retinal)IBA 01/2018 - 06/2008
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2014
4	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 09/2009
3	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2014
3	DystrophinIBA 01/2017 - 09/2014
3	Protons (Proton)IBA 01/2017 - 12/2004
3	Contrast MediaIBA 12/2016 - 07/2009
2	Amyloid beta-PeptidesIBA 03/2021 - 12/2009
2	Biological ProductsIBA 01/2021 - 01/2018
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019 - 07/2013
2	GoldIBA 01/2019 - 01/2015
2	ApolipoproteinsIBA 01/2018 - 01/2013
2	Formaldehyde (Formol)FDA Link 01/2018 - 06/2011
2	Peptides (Polypeptides)IBA 01/2018 - 01/2013
2	Antihypertensive Agents (Antihypertensives)IBA 10/2015 - 12/2009
2	Insulin (Novolin)FDA Link 08/2015 - 01/2015
2	Single-Domain AntibodiesIBA 08/2015 - 04/2015
2	Ketamine FDA LinkGeneric 03/2015 - 10/2012
2	Immunoglobulin FragmentsIBA 01/2012 - 10/2011
2	AntibodiesIBA 08/2010 - 12/2006
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	aducanumabIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Prothrombin (Factor II)IBA 01/2018
1	CarbonIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Amino Acids FDA Link 01/2018
1	CreatinineIBA 01/2018
1	AlbuminsIBA 01/2018
1	Pemetrexed (MTA)FDA Link 12/2017

Therapy/Procedure

2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2020
2	Lasers (Laser) 10/2017 - 05/2009
2	Decompression 10/2017 - 05/2009
2	Therapeutics 11/2012 - 03/2006
1	Off-Label Use 01/2021
1	Surgical Instruments (Clip) 01/2020
1	Catheter Ablation 01/2019
1	Catheters 01/2019